Trademarkia Logo

Canada

C$
GOLSAVI
REGISTERED

on 7 May 2020

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

ABBVIE BIOTECHNOLOGY LTD.

4th Floor, Washington House16 Church StreetHamilton HM 11

BM

Serial Number

1848355 filed on 19th Jul 2017

Registration Number

TMA1078245 registered on 7th May 2020

Registration expiry Date

7th May 2030

Correspondent Address

BAKER & MCKENZIE LLP

BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO

ONTARIO

CA

M5J2T3

GOLSAVI

Trademark usage description

pharmaceutical preparations and substances for the treatment of viral diseases, namely herpes, hepatitis, acquired immune deficiency syndrome (aids); Read More

Classification Information


Class [005]
Pharmaceutical preparations and substances for the treatment of viral diseases, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders, namely diabetes, bulimia nervosa, anorexia, obesity, hypothyroidism, hypoglycemia, gout, osteoarthritis, muscular dystrophy and anemia; pharmaceutical preparations and substances for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations and substances for the treatment of the musculoskeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations and substances for the treatment of cardiovascular and cardiopulmonary diseases and disorders; pharmaceutical preparations and substances for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, incontinence, inflammatory pelvic diseases and sexual dysfunction; pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical preparations and substances for the treatment of ophthalmic, respiratory and gastrointestinal diseases and disorders; pharmaceutical preparations and substances for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury and seizure disorders; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations and substances for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders and schizophrenia; pharmaceutical preparations and substances for the treatment of immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes


Classification kind code

11

Mark Details


Serial Number

1848355

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 8th Jan 2020
Advertised
Submitted for opposition 26
on 24th Dec 2019
Approved
Submitted for opposition 27
on 24th Dec 2019
Approval Notice Sent
Submitted for opposition 15
on 14th May 2019
Correspondence Created
Submitted for opposition 15
on 6th Nov 2018
Correspondence Created
Submitted for opposition 22
on 12th Jul 2018
Search Recorded
Submitted for opposition 20
on 12th Jul 2018
Examiner's First Report
Submitted for opposition 31
on 24th Jul 2017
Formalized
Submitted for opposition 1
on 20th Jul 2017
Created
Submitted for opposition 30
on 19th Jul 2017
Filed